Interleukin-6 and risk of colorectal cancer: results from the CLUE II cohort and a meta-analysis of prospective studies (Q36607913)

15 August 2017

0 references

Interleukin-6 and risk of colorectal cancer: results from the CLUE II cohort and a meta-analysis of prospective studies (English)

1 reference

15 August 2017

1 reference

1 reference

1 reference

6

Nader Rifai

1 reference

15 August 2017

8

Elizabeth A Platz

1 reference

15 August 2017

Artemisia Kakourou

1

1 reference

15 August 2017

Charalampia Koutsioumpa

2

1 reference

15 August 2017

David S Lopez

3

1 reference

15 August 2017

Judith Hoffman-Bolton

4

1 reference

15 August 2017

Gary Bradwin

5

1 reference

15 August 2017

Kathy J Helzlsouer

7

1 reference

15 August 2017

Konstantinos K Tsilidis

9

1 reference

15 August 2017

29 July 2015

1 reference

15 August 2017

Cancer Causes & Control

1 reference

15 August 2017

26

1 reference

15 August 2017

10

1 reference

15 August 2017

1449-1460

1 reference

IL-6 as a keystone cytokine in health and disease

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4763881

C-reactive protein, interleukin-6 and the risk of colorectal cancer: a meta-analysis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4763881

Plasma C-reactive protein, genetic risk score, and risk of common cancers in the Atherosclerosis Risk in Communities study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4763881

A prospective study of plasma inflammatory markers and risk of colorectal cancer in men.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4763881

Adipokines linking obesity with colorectal cancer risk in postmenopausal women

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4763881

Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4763881

Association of inflammatory markers with colorectal cancer incidence in the atherosclerosis risk in communities study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4763881

Inflammatory markers are associated with risk of colorectal cancer and chemopreventive response to anti-inflammatory drugs

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4763881

C-reactive protein and colorectal cancer risk: a systematic review of prospective studies

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4763881

C-reactive protein and colorectal adenoma in the CLUE II cohort

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4763881

White blood cell count and the risk of colon cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4763881

Celecoxib for the prevention of colorectal adenomatous polyps

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4763881

Celecoxib for the prevention of sporadic colorectal adenomas

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4763881

Relation between common polymorphisms in genes related to inflammatory response and colorectal cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4763881

Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4763881

C-reactive protein and the risk of incident colorectal cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4763881

Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4763881

Point: From animal models to prevention of colon cancer. Systematic review of chemoprevention in min mice and choice of the model system

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4763881

Cancer prevention in patients with inflammatory bowel disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4763881

Most effective colon cancer chemopreventive agents in rats: a systematic review of aberrant crypt foci and tumor data, ranked by potency

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4763881

The paradigm of IL-6: from basic science to medicine

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4763881

A data-based approach to diet questionnaire design and testing

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4763881

A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4763881

Adipokines and obesity are associated with colorectal polyps in adult males: a cross-sectional study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4763881

Association of CRP genetic variants with blood concentrations of C-reactive protein and colorectal cancer risk.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4763881

Evaluation of excess statistical significance in meta-analyses of 98 biomarker associations with cancer risk.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4763881

Circulating C-reactive protein concentrations and risks of colon and rectal cancer: a nested case-control study within the European Prospective Investigation into Cancer and Nutrition

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4763881

Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4763881

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4763881

Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4763881

Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4763881

Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis

20 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10552-015-0641-1

Leisure-Time Physical Activity and Reduced Plasma Levels of Obesity-Related Inflammatory Markers

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10552-015-0641-1

Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor alpha, NFKB1, and peroxisome proliferator-activated receptor gamma with colorectal cancer

21 January 2018

1 reference

12 December 2020

Serum albumin, bilirubin, and uric acid and the anatomic site-specific incidence of colon cancer

1 reference

12 December 2020

IL-6 signaling promotes tumor growth in colorectal cancer

1 reference

12 December 2020

C-Reactive Protein and the Risk of Cancer: A Mendelian Randomization Study

1 reference

12 December 2020

C-reactive protein-associated genetic variants and cancer risk: findings from FINRISK 1992, FINRISK 1997 and Health 2000 studies

1 reference

12 December 2020

Serum Interleukin-6, insulin, and HOMA-IR in male individuals with colorectal adenoma

1 reference

12 December 2020

10.1007/S10552-015-0641-1

Identifiers

DOI

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

26220152

1 reference